Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Cash Flow Reinvestment Rate
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Reinvestment Rate of 7.86x as of December 2025, reinvesting CN¥176.01 Million (capex CN¥7.07 Million plus investments CN¥-168.93 Million) from operating cash flow of CN¥22.41 Million. See 688193 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Rendu Biotechnology Co. Ltd. A.
Annual Cash Flow Reinvestment Rate for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year capital reinvestment analysis for Shanghai Rendu Biotechnology Co. Ltd. A. See Shanghai Rendu Biotechnology Co. Ltd. A financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.86x | CN¥176.01 Million | CN¥22.41 Million | CN¥7.07 Million | ▼ -40.7% |
| 2024 | 13.25x | CN¥323.10 Million | CN¥24.39 Million | CN¥10.52 Million | ▼ -33.5% |
| 2023 | 19.91x | CN¥342.31 Million | CN¥17.19 Million | CN¥20.39 Million | ▲ +2071.2% |
| 2021 | 0.92x | CN¥49.93 Million | CN¥54.44 Million | CN¥26.48 Million | ▲ +145.3% |
| 2020 | 0.37x | CN¥34.62 Million | CN¥92.61 Million | CN¥15.55 Million | ▼ -92.0% |
| 2019 | 4.66x | CN¥63.70 Million | CN¥13.67 Million | CN¥54.83 Million | — |